Literature DB >> 24064724

Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.

Marvin Xuejun Xu1, Linlin Zhao, Chaoyang Deng, Lu Yang, Yang Wang, Tao Guo, Lifang Li, Jianping Lin, Lirong Zhang.   

Abstract

Curcumin from the rhizome of Curcuma longa (zingiberaceae) has been reported to be a chemopreventive agent that affects cell proliferation by arresting the cell cycle in G2 and modulating the wnt signaling pathway. We found that curcumin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma (HCC) cells in a concentration-dependent manner. We identified that curcumin interrupts wnt signaling by decreasing β-catenin activity, which in turn suppresses the expression of β-catenin target genes (c-myc, VEGF and cyclin D1). Our results from molecular simulation of curcumin binding to Dvl2 protein and from binding free energy calculations suggest that curcumin may prevent axin recruitment to cellular membrane in order to maintain the functional β-catenin destruction complex in normal cells. This results in β-catenin being unable to accumulate in the nucleus, depriving the protein of its ability to bind with lymphoid enhancer factor/T cell-specific transcription factor (Lef/Tcf) and repressing its activation of target gene transcription. This may be one mechanism through which curcumin inhibits proliferation and induces apoptosis of HCC cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24064724     DOI: 10.3892/ijo.2013.2107

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  23 in total

1.  Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology.

Authors:  Yang Chen; Qian Li; Sisi Ren; Ting Chen; Bingtao Zhai; Jiangxue Cheng; Xiaoyan Shi; Liang Song; Yu Fan; Dongyan Guo
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

2.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

3.  Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.

Authors:  M Lee Schmidt; Howard Donninger; Geoffrey J Clark
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 4.  Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.

Authors:  Nighat Gull; Fareeha Arshad; Gowhar A Naikoo; Israr Ul Hassan; Mona Zamani Pedram; Arif Ahmad; Alaa A A Aljabali; Vijay Mishra; Saurabh Satija; Nitin Charbe; Poonam Negi; Rohit Goyal; Ángel Serrano-Aroca; Mazhar S Al Zoubi; Mohamed El-Tanani; Murtaza M Tambuwala
Journal:  J Gastrointest Cancer       Date:  2022-03-14

Review 5.  Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer.

Authors:  Debasish Bandyopadhyay
Journal:  Front Chem       Date:  2014-12-23       Impact factor: 5.221

6.  Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.

Authors:  Nicola Bortel; Sorin Armeanu-Ebinger; Evi Schmid; Bettina Kirchner; Jan Frank; Alexa Kocher; Christina Schiborr; Steven Warmann; Jörg Fuchs; Verena Ellerkamp
Journal:  Oncotarget       Date:  2015-12-01

7.  Curcumin inhibits the replication of enterovirus 71 in vitro.

Authors:  Ying Qin; Lexun Lin; Yang Chen; Shuo Wu; Xiaoning Si; Heng Wu; Xia Zhai; Yan Wang; Lei Tong; Bo Pan; Xiaoyan Zhong; Tianying Wang; Wenran Zhao; Zhaohua Zhong
Journal:  Acta Pharm Sin B       Date:  2014-07-24       Impact factor: 11.413

8.  Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells.

Authors:  Ruinian Zheng; Zhijian You; Jun Jia; Shunhuan Lin; Shuai Han; Aixue Liu; Huidong Long; Senming Wang
Journal:  Mol Med Rep       Date:  2015-12-24       Impact factor: 2.952

Review 9.  A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.

Authors:  Junlin Shi; Jill M Keller; Jian Zhang; Evan T Keller
Journal:  J Hepatocell Carcinoma       Date:  2014-03-06

Review 10.  Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma.

Authors:  Hui-Tzu Hsu; Chin-Wen Chi
Journal:  J Hepatocell Carcinoma       Date:  2014-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.